Xywav Gets FDA Approval to Treat Rare Sleep Disorder
First drug to be approved by the agency for idiopathic hypersomnia
Wildfires May Amplify Effect of PM₂.₅ Exposure on COVID-19 Dynamics
Increases in COVID-19 cases and deaths seen in 28 days following wildfire-linked increases in PM2.5
Health Coaching + Change in Early-Life Care Benefits Babies, Moms
Findings show reduced infant overweight and increased receipt of maternal postpartum care among low-income dyads
Physician’s Briefing Weekly Coronavirus Roundup
FDA OKs Third COVID-19 Shot for Vulnerable Americans
Authorization includes people who have had solid organ transplants and those whose immune systems are equally compromised
Third Dose of mRNA-1273 Boosts Immunity in Transplant Recipients
More patients receiving mRNA-1273 booster have serologic response with anti-receptor-binding domain antibody level of at least 100 U/mL
ASTRO Issues Guideline on RT for Soft Tissue Sarcoma in Adults
Multidisciplinary evaluation recommended for all cases of STS; when indicated, preoperative RT recommended over postoperative RT
Handling of Secondary Genetic Findings in Research Examined
When given more information, almost half of research participants who initially refused opted to accept secondary genetic findings
Brain-Training App Aids Cognitive Function After Brain Injury
Cognitive improvement seen in vets using self-administered program remotely for 12 weeks, with results sustained for an additional 12 weeks
High BMI Variability, Adverse Outcomes Linked in Predialysis CKD
Variabilities in metabolic syndrome components linked to prognosis, with worse prognosis for more components with high variability
